Association of angiotensin-converting enzyme i gene I/D polymorphism with endometrial but not with ovarian cancer

Gynecological Endocrinology

Volumn 28, Issue 11, 2012, Pages 889-891

  Correa Noronha, Silvana Aparecida Alves ^a   Ribeiro De Noronha, Samuel Marcos ^a   Alecrim, Cheryl ^a   Mesquita, Adriana De Carvalho ^a   Brito, Gabriela Soares Da Silva ^a   Junqueira, Michele Gilvana ^a   Leite, Daniela Batista ^a   De Carvalho, Cristina Valletta ^a   Da Silva, Ismael Dale Cotrim Guerreiro ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme; Endometrial cancer; Ovarian cancer

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 84867567608     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.683060     Document Type: Article

References (19)

1. Parkin DMD. Global cancer statistics 2002. CA Cancer J Clin 2005;55:74-108.
2. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006;98: 1123-1133.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
4. Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP, Yu MC. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003;63:573-578.
5. Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: The multiethnic cohort. Cancer Res 2003;63:6984-6987.
6. Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 2004;155: 42-46.
7. Correa SA, Fran LP, Costa-Neto CM, Oliveira L, Paiva AC, Shimuta SI. Relevant role of Leu265 in helix VI of the angiotensin AT1 receptor in agonist binding and activity. Can J Physiol Pharmacol 2002;80:426-430.
8. Correa SAA, Zalcberg H, Han SW, Oliveira L, Costa-Neto CM, Paiva ACM, Shimuta SI. Aliphatic amino acids in helix VI of the AT1 receptor play a relevant role in agonist binding and activity. Regul Pept 2002b;6:33-38.
9. Correa SAA, Pacheco NAS, Costa-Neto CM, Oliveira L, Pesquero JB, Han SW, Paiva ACM, Shimuta SI. New mutants of angiotensin II AT1 receptor expressed in CHO cells caused morphological change and inhibition of cell growth S.A.A. Regul Pept 2005;31:18-22.
10. Correa SAA, Noronha SMR, Nogueira-de-Souza NC, Carvalho CV, Massad-Costa AM, Linhares JJ, Gomes MTV, Silva IDCG. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009;10:51-58.
11. Erman A, Chen-Gal B, van Dijk DJ, Sulkes J, Kaplan B, Boner G, Neri A. Ovarian angiotensin-converting enzyme activity in humans: Relationship to estradiol, age, and uterine pathology. J Clin Endocrinol Metab 1996;81:1104-1107.
12. Saridogan E, Djahanbakhch O, Puddefoot JR, Demetroulis C, Dawda R, Hall AJ, Vinson GP. Type 1 angiotensin II receptors in human endometrium. Mol Hum Reprod 1996;2:659-664.
13. Vinson GP, Saridogan E, Puddefoot JR, Djahanbakhch O. Tissue reninangiotensin systems and reproduction. Hum Reprod 1997;12:651-662.
14. De Nuccio I, Salvati G, Genovesi G, Paolini P, Marcellini L, Schiavello V, Re M. Physiopathology of the renin-angiotensin system in the ovary. Minerva Endocrinol 1999;24:77-81.
15. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 2005;11: 2686-2694.
16. Shibata K, Kikkawa F, Mizokami Y, Kajiyama H, Ino K, Nomura S, Mizutani S. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. Tumour Biol 2005;26:9-16.
17. Ino K, Uehara C, Kikkawa F, Kajiyama H, Shibata K, Suzuki T, Khin EE, et al. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway. J Clin Endocrinol Metab 2003;88:3973-3982.
18. Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, et al. Clarifying the PROGINS allele association in ovarian and breast cancer risk: A haplotype-based analysis. J Natl Cancer Inst 2005;97:51-59.
19. Namazi S, Ardeshir-Rouhani-Fard S, Abedtash H. The effect of renin angiotensin system on tamoxifen resistance. Med Hypotheses 2011;77:152-155.